Drew A. Purdy

2.1k total citations · 2 hit papers
4 papers, 1.4k citations indexed

About

Drew A. Purdy is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Drew A. Purdy has authored 4 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Hematology. Recurrent topics in Drew A. Purdy's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Coronary Interventions and Diagnostics (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Drew A. Purdy is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Coronary Interventions and Diagnostics (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Drew A. Purdy collaborates with scholars based in United States, Netherlands and Chile. Drew A. Purdy's co-authors include Cheryl Wei, Gary S. Ledley, Mark J. Antonino, Arun Karunakaran, Paul A. Gurbel, Larry S. Dean, Udaya S. Tantry, Kevin P. Bliden, Shankar B. Patil and Kathleen Butler and has published in prestigious journals such as Circulation and Journal of the American College of Cardiology.

In The Last Decade

Drew A. Purdy

4 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

2009 794 citations Paul A. Gurbel, Kevin P. Bliden et al. Circulation profile →
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

2008 498 citations Stephen D. Wiviott, Eugene Braunwald et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Drew A. Purdy United States	3	1.3k	661	411	160	84	4	1.4k
Bonnie L. Hiatt United States	6	1.3k 1.0×	687 1.0×	382 0.9×	164 1.0×	185 2.2×	9	1.4k
Shankar B. Patil United Kingdom	5	1.2k 1.0×	559 0.8×	461 1.1×	102 0.6×	78 0.9×	8	1.3k
Martin M. Zenni United States	20	1.3k 1.1×	749 1.1×	369 0.9×	177 1.1×	105 1.3×	41	1.5k
Willem J.M. Dewilde Netherlands	9	1.6k 1.2×	488 0.7×	456 1.1×	75 0.5×	48 0.6×	19	1.7k
Guillaume Cayla France	14	1.0k 0.8×	551 0.8×	227 0.6×	53 0.3×	50 0.6×	32	1.1k
Lars Wallentin Sweden	8	813 0.6×	352 0.5×	299 0.7×	49 0.3×	56 0.7×	13	983
Jan A.S. Van der Heyden Netherlands	14	988 0.8×	473 0.7×	226 0.5×	81 0.5×	60 0.7×	30	1.1k
Donald Palisaitis Canada	14	773 0.6×	320 0.5×	288 0.7×	72 0.5×	238 2.8×	32	910
Paul W.A. Janssen Netherlands	14	693 0.5×	354 0.5×	202 0.5×	77 0.5×	61 0.7×	30	792
Jayne Prats United States	18	1.1k 0.9×	735 1.1×	298 0.7×	28 0.2×	48 0.6×	65	1.3k

Countries citing papers authored by Drew A. Purdy

Since Specialization

Citations

This map shows the geographic impact of Drew A. Purdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew A. Purdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew A. Purdy more than expected).

Fields of papers citing papers by Drew A. Purdy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew A. Purdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew A. Purdy. The network helps show where Drew A. Purdy may publish in the future.

Co-authorship network of co-authors of Drew A. Purdy

This figure shows the co-authorship network connecting the top 25 collaborators of Drew A. Purdy. A scholar is included among the top collaborators of Drew A. Purdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew A. Purdy. Drew A. Purdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Cohen, Mauricio G., Drew A. Purdy, Joseph S. Rossi, et al.. (2010). FACTOR IXA INHIBITION WITH REG1 PROVIDES RAPID ONSET, STABLE AND ACTIVELY CONTROLLED ANTICOAGULATION DURING PCI. Journal of the American College of Cardiology. 55(10). A206.E1940–A206.E1940. 1 indexed citations

2.

Cohen, Mauricio G., Drew A. Purdy, Joseph S. Rossi, et al.. (2010). First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention. Circulation. 122(6). 614–622. 77 indexed citations

3.

Gurbel, Paul A., Kevin P. Bliden, Kathleen Butler, et al.. (2009). Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease. Circulation. 120(25). 2577–2585. 794 indexed citations breakdown →

4.

Wiviott, Stephen D., Eugene Braunwald, Dominick J. Angiolillo, et al.. (2008). Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38. Circulation. 118(16). 1626–1636. 498 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact